Bunzl Finance Plc - LEI: 549300G276IH2GSE0E88
Bunzl plc - LEI: 213800Q1Q9DV4L78UM09
THIS ANNOUNCEMENT IS NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW
8 October 2024
BUNZL FINANCE PLC
PUBLICATION OF PRICING SUPPLEMENT IN RELATION TO THE ISSUE BY BUNZL FINANCE PLC OF €500,000,000 3.375 PER CENT. SENIOR UNSECURED NOTES DUE 2032 (THE "NOTES") UNCONDITIONALLY AND IRREVOCABLY GUARANTEED BY BUNZL PLC UNDER THE £1,500,000,000 EURO MEDIUM TERM NOTE PROGRAMME OF BUNZL FINANCE PLC
Bunzl Finance plc (the "Issuer") has today published a pricing supplement dated 7 October 2024 setting out details of the Notes (the "Pricing Supplement"). The Pricing Supplement should be read in conjunction with the admission particulars dated 20 November 2023, as supplemented by supplementary admission particulars dated 20 September 2024, including all documents incorporated therein by reference (together, the "Admission Particulars").
To view the Pricing Supplement, please paste the following URL into the address bar of your browser:
https://www.bunzl.com/investors/shareholder-information/debt-information/
For further information please contact:
Bunzl Finance plc
York House
45 Seymour Street
London
W1H 7JT
United Kingdom
Email: Suzanne.Jefferies@Bunzl.com
Attention: Suzanne Jefferies
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Pricing Supplement and the Admission Particulars may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Admission Particulars) only and are not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Admission Particulars is not addressed. Prior to relying on the information contained in the Pricing Supplement and/or the Admission Particulars you must ascertain from the Admission Particulars whether or not you are part of the intended addressees of the information contained therein.
The Pricing Supplement and the Admission Particulars do not constitute an offer of securities for sale in the United States. The Notes have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America, and may not be offered or sold to U.S. persons or to persons within the United States of America (as such terms are defined in Regulation S under the Securities Act), except pursuant to an exemption from the Securities Act. For a further description of certain restrictions on offers and sales of the Notes, see the "Subscription and Sale" section in the Admission Particulars.
Your right to access this service is conditional upon complying with the above requirement.
No offer or invitation to acquire any securities is being made pursuant to this announcement.
END.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
